(2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide

C50H70N8O6 — CID 170066536

IUPAC(2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide
SMILESCCn1c(C2=C([C@H](C)OC)N=CC(N3CCN(C)CC3)C2)c2c3cc(ccc31)-c1cc(O)cc(c1)C[C@H](NC(=O)[C@@H](NC)C1CCCC1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C50H70N8O6/c1-8-57-43-16-15-34-26-38(43)40(46(57)39-27-36(29-52-44(39)31(2)63-7)56-20-18-55(6)19-21-56)28-50(3,4)30-64-49(62)41-14-11-17-58(54-41)48(61)42(24-32-22-35(34)25-37(59)23-32)53-47(60)45(51-5)33-12-9-10-13-33/h15-16,22-23,25-26,29,31,33,36,41-42,45,51,54,59H,8-14,17-21,24,27-28,30H2,1-7H3,(H,53,60)/t31-,36?,41-,42-,45-/m0/s1
InChIKeyAZTQKEKHLMDRMJ-ZNBMYXSFSA-N
MW879.16 g/mol
LogP5.30
Rot. Bonds9

About (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide

(2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide (PubChem CID 170066536) has the molecular formula C50H70N8O6 and a molecular weight of 879.16 g/mol. Its IUPAC name is (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide.

Molecular Properties

Compound Name(2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide
PubChem CID170066536
Molecular FormulaC50H70N8O6
Molecular Weight879.16 g/mol
Exact Mass878.54
IUPAC Name(2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide
SMILESCCn1c(C2=C([C@H](C)OC)N=CC(N3CCN(C)CC3)C2)c2c3cc(ccc31)-c1cc(O)cc(c1)C[C@H](NC(=O)[C@@H](NC)C1CCCC1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C50H70N8O6/c1-8-57-43-16-15-34-26-38(43)40(46(57)39-27-36(29-52-44(39)31(2)63-7)56-20-18-55(6)19-21-56)28-50(3,4)30-64-49(62)41-14-11-17-58(54-41)48(61)42(24-32-22-35(34)25-37(59)23-32)53-47(60)45(51-5)33-12-9-10-13-33/h15-16,22-23,25-26,29,31,33,36,41-42,45,51,54,59H,8-14,17-21,24,27-28,30H2,1-7H3,(H,53,60)/t31-,36?,41-,42-,45-/m0/s1
InChIKeyAZTQKEKHLMDRMJ-ZNBMYXSFSA-N
XLogP5.30
TPSA153.00 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms64
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500879.16
LogP ≤ 55.30
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide?
The IUPAC name of (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide (CID 170066536) is (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide.
What is the SMILES notation for (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide?
The canonical SMILES for (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide is CCn1c(C2=C([C@H](C)OC)N=CC(N3CCN(C)CC3)C2)c2c3cc(ccc31)-c1cc(O)cc(c1)C[C@H](NC(=O)[C@@H](NC)C1CCCC1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2.
What is the InChIKey of (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide?
The InChIKey is AZTQKEKHLMDRMJ-ZNBMYXSFSA-N. The full InChI is InChI=1S/C50H70N8O6/c1-8-57-43-16-15-34-26-38(43)40(46(57)39-27-36(29-52-44(39)31(2)63-7)56-20-18-55(6)19-21-56)28-50(3,4)30-64-49(62)41-14-11-17-58(54-41)48(61)42(24-32-22-35(34)25-37(59)23-32)53-47(60)45(51-5)33-12-9-10-13-33/h15-16,22-23,25-26,29,31,33,36,41-42,45,51,54,59H,8-14,17-21,24,27-28,30H2,1-7H3,(H,53,60)/t31-,36?,41-,42-,45-/m0/s1.
What are the key properties of (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide?
(2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide has a molecular weight of 879.16 g/mol, XLogP of 5.30, 9 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-cyclopentyl-N-[(8S,14S)-22-ethyl-4-hydroxy-21-[6-[(1S)-1-methoxyethyl]-3-(4-methylpiperazin-1-yl)-3,4-dihydropyridin-5-yl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]-2-(methylamino)acetamide is sourced from PubChem (CID 170066536), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).